Work by our group and others demonstrated that in chronic myeloid leukemia (CML) Bcr-Abl induced ROS regulates the PI3K/Akt pathway [20], [21]. Here, AKT1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.